Altered Hypercoagulability Factors in Patients with Chronic Chagas Disease: Potential Biomarkers of Therapeutic Response.

Altered Hypercoagulability Factors in Patients with Chronic Chagas Disease: Potential Biomarkers of Therapeutic Response.

Thromboembolic events were described in patients with Chagas disease without cardiomyopathy. We aim to confirm if there is a hypercoagulable state in these patients and to determine if there is an early normalization of hemostasis factors after antiparasitic treatment. Ninety-nine individuals from C...

Full description

Bibliographic Details
Main Authors:	Maria-Jesus Pinazo, Elizabeth de Jesus Posada, Luis Izquierdo, Dolors Tassies, Alexandre-Ferreira Marques, Elisa de Lazzari, Edelweiss Aldasoro, Jose Muñoz, Alba Abras, Silvia Tebar, Montserrat Gallego, Igor Correia de Almeida, Joan-Carles Reverter, Joaquim Gascon
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	http://europepmc.org/articles/PMC4700971?pdf=render

Similar Items

Immunosuppression and Chagas disease: a management challenge.
by: María-Jesús Pinazo, et al.
Published: (2013-01-01)

Pulmonary infiltrates and eosinophilia in a 25-year-old traveler.
by: Jose Muñoz, et al.
Published: (2013-01-01)

Chagas disease among the Latin American adult population attending in a primary care center in Barcelona, Spain.
by: Carme Roca, et al.
Published: (2011-04-01)

Prevalence of Chagas disease in Latin-American migrants living in Europe: a systematic review and meta-analysis.
by: Ana Requena-Méndez, et al.
Published: (2015-02-01)

Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives
by: Maria-Jesus Pinazo, et al.
Published: (2015-05-01)

Characterization of digestive involvement in patients with chronic T. cruzi infection in Barcelona, Spain.
by: María-Jesús Pinazo, et al.
Published: (2014-08-01)

Introducing automation to the molecular diagnosis of Trypanosoma cruzi infection: A comparative study of sample treatments, DNA extraction methods and real-time PCR assays.
by: Alba Abras, et al.
Published: (2018-01-01)

Evaluation of a chemiluminescent enzyme-linked immunosorbent assay for the diagnosis of Trypanosoma cruzi infection in a nonendemic setting
by: Luis Izquierdo, et al.
Published: (2013-11-01)

Hypercoagulability and thrombosis
by: Maria Domenica Cappellini, et al.
Published: (2013-03-01)

The endothelium and hypercoagulability
by: Mbanya, Dora Ngum Shu epouse
Published: (1990)

Perioperative hypercoagulability
by: Lyness, Craig Anthony
Published: (2017)

Socio-cultural aspects of Chagas disease: a systematic review of qualitative research.
by: Laia Ventura-Garcia, et al.
Published: (2013-01-01)

Hypercoagulability in multiple myeloma
by: E S Urnova, et al.
Published: (2014-07-01)

In silico Design of an Epitope-Based Vaccine Ensemble for Chagas Disease
by: Lucas Michel-Todó, et al.
Published: (2019-11-01)

Multi-criteria decision analysis approach for strategy scale-up with application to Chagas disease management in Bolivia.
by: Maria-Jesus Pinazo, et al.
Published: (2021-03-01)

Corrigendum: In silico Design of an Epitope-Based Vaccine Ensemble for Chagas Disease
by: Lucas Michel-Todó, et al.
Published: (2020-01-01)

Plasma-Derived Extracellular Vesicles as Potential Biomarkers in Heart Transplant Patient with Chronic Chagas Disease
by: Nuria Cortes-Serra, et al.
Published: (2020-08-01)

Amaryllidaceae plants: a potential natural resource for the treatment of Chagas disease
by: Nieves Martínez-Peinado, et al.
Published: (2021-06-01)

Hypercoagulability and ischemic stroke in young patients
by: M. Martínez-Martínez, et al.
Published: (2010-01-01)

Hypercoagulability in pregnant trauma patients
by: Bryan A Cotton, et al.
Published: (2021-08-01)

Chronometric vs. Structural Hypercoagulability
by: Carmen Delianu, et al.
Published: (2021-12-01)

FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
by: Oshrat E. Tayer-Shifman, et al.
Published: (2011-05-01)

FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
by: Oshrat E. Tayer-Shifman, et al.
Published: (2011-01-01)

Hypercoagulability in different respiratory diseases
by: Howida Mohamed Abd Elsalam, et al.
Published: (2013-04-01)

The blood coagulation mechanism and hypercoagulability
by: Tate, Geoffrey Michael
Published: (1990)

Development of Diagnostics for Chagas Disease: Where Should We Put Our Limited Resources?
by: Albert Picado, et al.
Published: (2017-01-01)

High prevalence of S. Stercoralis infection among patients with Chagas disease: A retrospective case-control study.
by: Pedro Puerta-Alcalde, et al.
Published: (2018-01-01)

A strategy for scaling up access to comprehensive care in adults with Chagas disease in endemic countries: The Bolivian Chagas Platform.
by: Maria-Jesus Pinazo, et al.
Published: (2017-08-01)

Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis
by: Ana Requena-Méndez, DrPhD, et al.
Published: (2017-04-01)

Chagas cardiomyopathy: the potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage.
by: Ana Garcia-Alvarez, et al.
Published: (2010-01-01)

COVID-19 and Hypercoagulability: A Review
by: Asim Kichloo MD, et al.
Published: (2020-10-01)

The hypercoagulable states in anaesthesia and critical care
by: Bala D Bande, et al.
Published: (2014-01-01)

Potential Mechanisms of Cancer-Related Hypercoagulability
by: Nicola J. Nasser, et al.
Published: (2020-02-01)

The Risk of Hypercoagulability in Ovarian Hyperstimulation Syndrome
by: Damir Danolić, et al.
Published: (2015-01-01)

Mesenteric vessel thrombosis and hypercoagulable states
by: Jasmina Ahluwalia, et al.
Published: (2011-01-01)

Hypercoagulability in hereditary hemorrhagic telangiectasia with epilepsy
by: Josef Finsterer, et al.
Published: (2015-03-01)

Integrated laboratory coagulation tests in hypercoagulation diagnosis and thrombosis risk assessment. Part I. The pathophysiology of thrombosis and hypercoagulation
by: E. N. Lipets, et al.
Published: (2015-10-01)

Characterization of digestive disorders of patients with chronic Chagas disease in Cochabamba, Bolivia
by: Jimy-Jose Pinto, et al.
Published: (2019-02-01)

Hipercoagulabilidade e câncer de pulmão Hypercoagulability and lung cancer
by: Felipe Costa de Andrade Marinho, et al.
Published: (2008-05-01)

Strengthening the Bolivian pharmacovigilance system: New surveillance strategies to improve care for Chagas disease and tuberculosis.
by: Nuria Cortes-Serra, et al.
Published: (2020-09-01)